Work

A Phase 1b, Multi-Center, Randomized, Placebo-Controlled Trial of Inhaled Seralutinib in Subjects with WHO Group 1 Pulmonary Arterial Hypertension

Year: 2021

Type: conference-abstract

DOI: 10.1164/ajrccm-conference.2021.203.1_meetingabstracts.a3602

Authors: R.P. Frantz, K.B. Highland, J.W. McConnell, C.D. Burger, R.F. Roscigno, M. Cravets, R. McCaffrey, L.S. Zisman, L. Howard

Institutions: Mayo Clinic, Cleveland Clinic, Norton Healthcare, Norton Hospital, Mayo Clinic in Florida, Gossamer Bio (United States), Imperial College Healthcare NHS Trust

Language: English

Topic: Pulmonary Hypertension Research and Treatments

Subfield: Pulmonary and Respiratory Medicine

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: gold

OpenAlex ID: W4233318631

Cites:

Cited by: 3

Related to: 10